ACC 2023: SGLT2i Use - Dos and Don'ts

ACC 2023 Conference Coverage

A. Armbruster

SURPASS 2: Tirzepatide Versus Once-Weekly Semaglutide

Juan Frias

Weightloss in Menopause

Susan Brian

The Deadly Paradox: Current Practice, Driven by Guidelines, Is Not A…

Michael Makover

Obesity and Heart Health: Weighing the Facts

The North American Thrombosis Forum (NATF)

K. D. Palmer Emrich

Colchicine: Now and What’s Next?

National Lipid Association

C. Ballantyne

The Differences Between the Products of GLP1's and GLP/GIPs

Susan Brian

Medical Treatment of Hypercortisolism With Relacorilant: Final Resul…

Heart in Diabetes (HiD)

R. Pivonello

Discussing Retatrutide: A GIP, GLP-1, and Glucagon Receptor Agonist

Susan Brian

Vitamin D Deficiency

Keck School of Medicine of USC

V. Gevorgyan

Switch, Change, Rearrange: Diabetes Medication Transitions, De-presc…

Jennifer Rosselli

S. Twillmann

ACC 2024 Insights: A Plant-Based Diet

ACC 2024 Insights

N. Barnard

New Research: Side Effect of GLP1

Susan Brian

The Best of AHA23 for the Primary Care Doctor

Cecilia Bahit

An Introduction to Tirzepatide for Weightloss

Susan Brian

Diabetes Burden in Metabolic Syndrome and Obesity

Baylor College of Medicine

E. Trofimovsky

Understanding Weight Bias and Its Impact

Baylor College of Medicine

J. Nadglowski, Jr.

How to Prescribe Anti Obesity Medications

Beverly Tchang

New Generation of Stents Are Needed for Renal Vein Stenting

Transformative Endovascular Decisions Conference

M. Razavi

Predictors of Poor Response to Semaglutide for Weight Management

Ploutarchos Tzoulis